Stay updated with breaking news from Arcturus Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic disorders have been highly prevalent since the past several years. Amongst all the genetic anomalies known to humankind, urea cycle disorders (UCDs) and ornithine transcarbamylase (OTC) deficiency are highly prevalent around the world. OTC deficiency is inherited in an X-linked recessive manner – males are m...
Global Ornithine Transcarbamylase Deficiency Treatment Market to Reach US$ 900 Mn by 2030 factmrJune 10, 2021 Genetic disorders have been highly prevalent since the past several years. Amongst all the genetic anomalies known to humankind, urea cycle disorders (UCDs) and ornithine transcarbamylase (OTC) deficiency are highly prevalent around the world. OTC deficiency is inherited in an X-linked recessive manner – males are more commonly affected as compared to females. The prevalence of OTC deficiency is estimated to range from 1 in 14,000 to 77,000 people. Therefore, healthcare providers ha...